This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Triple-S Management (GTS) Soars to a 52-Week High, Time to Cash Out?
by Zacks Equity Research
Triple-S Management Corporation is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.
Top Research Reports for General Dynamics, Enbridge & CSX Corporation
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Enbridge (ENB) and CSX Corporation (CSX).
5 Reasons to Add WellCare Health Plans to Your Portfolio
by Zacks Equity Research
WellCare Health Plans (WCG) looks lucrative, promising better yield for investors on the back of five factors.
Here's Why Teladoc Reaches a 52 Week High, Stock Up 22%
by Zacks Equity Research
Teladoc's (TDOC) robust results and a favorable guidance increase the stock price.
Humana (HUM) Tops Q1 Earnings and Revenues, Lifts Guidance
by Zacks Equity Research
Humana's (HUM) Q1 draws stength from Medicare Advantage enrollment growth, solid segmental performances, lower taxes as well as a favorable impact of share buybacks.
Humana's (HUM) Q1 Earnings Top Estimates, Raises Guidance
by Zacks Equity Research
Humana's (HUM) Q1 earnings reflect Medicare Advantage enrollment growth and solid performance across all segments.
Why Humana Inc. (HUM) Might Surprise This Earnings Season
by Zacks Equity Research
Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
Humana (HUM) Q1 Earnings to Benefit From Medicare Business
by Zacks Equity Research
Humana (HUM) Q1 earnings should see upside from higher revenues in Retail segment, but investments may increase total expenses.
Will Teladoc (TDOC) Q1 Earnings Buoy On Severe Flu Season?
by Zacks Equity Research
We expect Teladoc's (TDOC) earnings to see an upside from the recent severe flu season,which should lead to higher patient visits.
Will Higher Medicare Revenues Aid Aetna (AET) Q1 Earnings?
by Zacks Equity Research
Aetna (AET) Q1 earnings should benefit from growth in its Medicare business and a lower tax rate, partly offset by a decline in revenues.
HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare (HCA) Q1 results should see an upside from flu-related activity and lower taxes, partly offset by pressure on volumes.
Tenet Healthcare's (THC) Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Tenet Healthcare's (THC) earnings are likely to beat estimates in the first quarter, riding high on the robust performance of its Ambulatory segment.
Company News for Apr 24, 2018
by Zacks Equity Research
Companies in the news are: ALK,ASB,HSIC,HUM
Anthem (ANTM) Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Anthem's (ANTM) first-quarter earnings might gain from a solid Government business. However, persistent softness in Individual business is likely to affect overall results.
Can Government Business Drive Centene's (CNC) Q1 Earnings?
by Zacks Premium Research
Centene's (CNC) first quarter 2018 results are likely to benefit from Medicaid expansion as well as rising participation in exchanges.
UnitedHealth (UNH) Q1 Earnings & Revenues Top, View Lifted
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings reflect double-digit growth across each business line.
UnitedHealth (UNH) Q1 Earnings to Gain From Optum Revenues
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings should see an upside from higher revenues in its health services segment named Optum.
Will UnitedHealth (UNH) Q1 Earnings Buoy on Revenue Growth?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings should see an upside from revenue growth at both its segments - Optum and UnitedHealthcare.
Top Stock Reports for General Dynamics, Verizon & AIG
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Verizon Communications (VZ) and American International Group (AIG).
Humana (HUM) Shores Up Government Business With FPG Buyout
by Zacks Equity Research
Humana's (HUM) Medicare business is expected to benefit from its strategic acquisitions.
Check These 3 Health Insurers to Reap High Returns in Q2
by Zacks Equity Research
We streamline our search to three best insurance bets with potential to turn investors rich by garnering fat returns.
Medicare Rate Up More than Expected, Health Insurers to Gain
by Zacks Equity Research
Increase in Medicare Advantage reimburse rates bodes well for health insurers.
Walmart Takes on Amazon Again, Look What It's Done This Time
by Zacks Equity Research
Walmart (WMT) plans to introduce Walmart2World money transfer service in collaboration with MoneyGram International.
Can Walmart Fortify Position Against Amazon With Humana Deal?
by Zacks Equity Research
Walmart's (WMT) plans to extend existing ties with Humana to enhance healthcare offerings, seems another bullet shot by the former in its war against the e-commerce king.
5 Reasons Why Anthem (ANTM) is a Lucrative Investment Option
by Zacks Equity Research
Anthem (ANTM) appears an impressive investment option on the back of rising membership, favorable investment income as well as solid financial health.